Yissum - Research Development Company of the Hebrew University

Nasal Technology for Delivering Active Plant–Based Oils

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Nasal Technology for Delivering Active Plant–Based Oils

Project ID : 6-2019-6708

Description of the technology

Categories:

Life Science & Biotechnology

Technology Keywords:

Nasal administration, CNS active oil, neurodegenerative diseases, CNS

Development Stage:

Formulation and experiments in animals

Patent Status:

USpatent application

Highlights:

We have designed and developed formulations based on a new technology for nasal administration of active plant –based oils for brain and CNS diseases therapy.

In vivo results show delivery to brain by our nasal technology and high efficiency in pain animal model.

Key Features

  • Nasal delivery of active plant–based oils to the brain and central nervous system
  • Better bioavailability by nasal route than by oral or subcutaneous routes
  • Carrier ingredients already have FDA approval
  • Offering set of benefits for prevention or slowing down neurodegenerative diseases

Researcher Information:

https://medicine.ekmd.huji.ac.il/En/Publications/ResearchersPages/pages/elkat.aspx

Project manager

Shani Bullock
VP, Business Development, Healthcare

Project researchers

Elka Touitou
HUJI, School of Medicine - IMRIC
School of Pharmacy- Institute for Drug Research

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Diagnostic
  • Therapeutic
  • Other Medical/Health Related
  • Agro and Marine biotech
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Life Science & Biotechnology
  • cns

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.